Navigation Links
Federal nanotech risk research plan still comes up short
Date:2/19/2008

WASHINGTON, DC An improved but still flawed government-wide plan for nanotechnology risk research is the result of a broken system. Federally-funded studies essential to managing possible risks from this cutting-edge technology should be guided by a top-down strategy tied to projected commercialization, expected human and environmental exposures, and the regulatory decision-making process.

The National Nanotechnology Initiatives (NNI) Nanotechnology Environmental and Health Implications (NEHI) Working Group recently released its strategy for nanotechnology environmental, health and safety research. The strategy outlines an improved focus on risk research for more than 20 federal agencies, including the Environmental Protection Agency (EPA), the Food & Drug Administration (FDA) and the Consumer Product Safety Commission (CPSC). Earlier drafts of the strategy received widespread criticism from industry officials, policy experts and congressional lawmakers for being merely a list of general nanotechnology risk research categories. The new strategy makes substantial strides towards identifying prioritized research needs and assigning lead agencies to address these needs.

Also just released, the new EPA Office of Research & Development nanotechnology risk research plan appears to be in lock step with the NEHI strategy. The EPA plan includes important studies on risk assessment methods and life-cycle analysis to determine the eventual fate of nanomaterials.

But major hurdles still stand in the way of the public, industry and government obtaining a better understanding of the risks posed by nanomaterials and how to limit those risks. Necessary resources for nanotechnology risk research are few and far between in relevant oversight agencies such as the EPA, FDA and CPSC. In addition, a limited investment by the NNI on occupational exposure research can only increase dangers to those most susceptible workers.

The truth is that
'/>"/>

Contact: Colin Finan
colin.finan@wilsoncenter.org
202-691-4321
Project on Emerging Nanotechnologies
Source:Eurekalert

Page: 1 2

Related biology technology :

1. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
2. Federal Trade Commission Clears Kyphons Acquisition of Non-Vertebroplasty Spine-Related Assets of Disc-O-Tech
3. NIH Announces Advanced Cell Technologys Single Cell Embryo Biopsy Technique as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding
4. Zimmer Announces Settlement of Federal Investigation
5. DelSite Nasal Powder Technology Could Reduce Recently Reported Waste in Federal Vaccine Program
6. Federally-Funded Study Shows More Women Can Avoid Hysterectomy for Common Problem
7. Cephalon Statement on Federal Trade Commission Action Regarding PROVIGIL Patent Settlements
8. Stevens to host Nanoscience/Nanotechnology & Corrosion symposium, Nov. 13
9. NASA technology forms the basis for a new nanotechnology company
10. Superbugs, shapes and nanotechnology
11. Siemens and Xintek Form Joint Venture to Develop Nanotechnology-Enabled Multi-Pixel X-ray Tubes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...mbassador to also Visit Detroit , ...vid Appia, French Ambassador for International Inv...nce Agency, , , , ,What: Ambassador Appia is avai...iness initiatives adopted by France to further dev...for innovation and development., , ,When: Availabl...
(Date:11/24/2009)...ov. 24 Sigma-Aldrich Cor...e NASDAQ OMX conference on Tuesday, December 1st a...d parties may listen via live audio broadcast over...ig m a a ldrich.com/ . Users can click the "... Sigma-Aldrich: Sigma-Aldrich is a leading Life ...
(Date:11/24/2009)...AI, Nov. 24 /PRNewswire-Asia/ -- Shanghai Biolaxy ...stration (SFDA) has approved the,investigational n...ject,(Nodlin), an innovative insulin formulation t... to initiate its first phase I clinical study. ,...igh blood glucose and poor,metabolism. The complic...
(Date:11/24/2009)...vember 24 Shire plc (LSE...harmaceutical company, today,announced that it has...for,velaglucerase alfa, the company,s enzyme repla... Type 1 Gaucher disease. This is the third marketi...n submitted, with previous,submissions in the Unit...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4
..., April 20 Bionovo, Inc. (Nasdaq: BNVI ) today ...new data on the nature of the active compound and ...g candidate, BN108. The presentation is being made...n of Cancer Research (AACR) in Denver, today. , ,... , , , BN108, an aqueous extract of Anem...
...ned Physicians Join World Class Group of Advisors ... today announced the expansion of its Clinical Adv...SA, and G. Ralph Corey, MD, as the sixth and seven...leaders. Dr. Batts is a Professor of Medicine at ...tious Diseases at its Kalamazoo Campus. Dr. Corey...
...,s largest independent dermatology company, acquir..., New global business will have combined revenues ...ct pipeline , , Significant step forward to grow ...new revenue and synergy opportunities , , LONDON,...Stiefel Laboratories Inc. today announced that the...
Other Biology Technology:Bionovo Announces Publication of Data on Active Compound and Mechanism of Action for Its Preclinical Cancer Treatment, BN108 2Bionovo Announces Publication of Data on Active Compound and Mechanism of Action for Its Preclinical Cancer Treatment, BN108 3Trius Appoints Don Batts and Ralph Corey to Clinical Advisory Board 2GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business 2GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business 3GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business 4
(Date:11/25/2009)... may be used to boost resistance to, or slow, the ... Medicine researchers report in a study published .... , Parkinson,s disease is caused by a degenerat... known as the substantia nigra, which is responsib... dopamine in late-stage Parkinson,s causes symptom...
(Date:11/25/2009)...ers and ambulance workers faced a terrifying rescu...attled to save people from the collapsing Twin Tow...cuated as many people as they could in an area whi...g their jobs even harder was the problem of poor c...ves jammed mobile networks with calls and the emer...
(Date:11/25/2009)... linchpin of the environment, where atmosphere, bi...students see soil as "just dirt" a place to grow ...re challenged with the task of helping students an...soil in the environment. , A collaborative proj...University of Nebraska-Lincoln, Oregon State Unive...
Breaking Biology News(10 mins):Hormone ghrelin can boost resistance to Parkinson's disease 2Magic box for mission impossible 2Magic box for mission impossible 3It's not just dirt! 2Morpace Reports 3A H1N1 Flu Could Adversely Impact Holiday Shopping Season 60094 1Morpace Reports 3A H1N1 Flu Could Adversely Impact Holiday Shopping Season 60094 2Rcadia Medical Imaging Wins 2009 AuntMinnie com Best New Radiology Vendor Award 5701 1Rcadia Medical Imaging Wins 2009 AuntMinnie com Best New Radiology Vendor Award 5701 2Rcadia Medical Imaging Wins 2009 AuntMinnie com Best New Radiology Vendor Award 5701 3Shire Presents Results of Five Lialda 28R 29 28mesalamine 29 Analyses at ACG 2009 Annual Scientific Meeting 5697 1Shire Presents Results of Five Lialda 28R 29 28mesalamine 29 Analyses at ACG 2009 Annual Scientific Meeting 5697 2Shire Presents Results of Five Lialda 28R 29 28mesalamine 29 Analyses at ACG 2009 Annual Scientific Meeting 5697 3Shire Presents Results of Five Lialda 28R 29 28mesalamine 29 Analyses at ACG 2009 Annual Scientific Meeting 5697 4Shire Presents Results of Five Lialda 28R 29 28mesalamine 29 Analyses at ACG 2009 Annual Scientific Meeting 5697 5Shire Presents Results of Five Lialda 28R 29 28mesalamine 29 Analyses at ACG 2009 Annual Scientific Meeting 5697 6Shire Presents Results of Five Lialda 28R 29 28mesalamine 29 Analyses at ACG 2009 Annual Scientific Meeting 5697 7Shire Presents Results of Five Lialda 28R 29 28mesalamine 29 Analyses at ACG 2009 Annual Scientific Meeting 5697 8
....C. -- A new study led by Duke University research...cially those that had been converted into farm fie...ersity. , But that,s a good thing, say the study...nd soils, natural conditions. , "It sounds counte...wetlands, decreased soil bacterial diversity repre...
...nd downs of Greenland,s ice sheet , Studies have...g, likely because of increasing average summer air...stigate the total loss of the ice sheet,s mass fro...eters: ice discharge, which is obtained from remot...ich is derived from a model of melting ice and sno...
...s from the universities of Leicester and Cambridge...shed new research in the journal Geology this mo... year old mystery. , The 500 million year-old fos...er a century ago, still provide one of the most re...he beautiful silvery fossils show the true nature ...
Other Biology News:Shifts in soil bacterial populations linked to wetland restoration success 2Shifts in soil bacterial populations linked to wetland restoration success 3AGU journal highlights: Nov. 11, 2008 2AGU journal highlights: Nov. 11, 2008 3AGU journal highlights: Nov. 11, 2008 4AGU journal highlights: Nov. 11, 2008 5AGU journal highlights: Nov. 11, 2008 6AGU journal highlights: Nov. 11, 2008 7AGU journal highlights: Nov. 11, 2008 8AGU journal highlights: Nov. 11, 2008 9AGU journal highlights: Nov. 11, 2008 10Deep heat solution to 500-million year mystery 2
Anti-Echovirus LIGHT DIAGNOSTICS Antibody, Unconjugated from CHEMICON
Mouse Anti-JNK, phospho (Thr183 / Thr185) Antibody, Unconjugated from Raybiotech, Inc.
Goat Anti-gamma chain Polyclonal Antibody, HRP Conjugated from Exalpha Biologicals, Inc.
Rabbit Anti-Human ZFP91 Polyclonal Antibody, Unconjugated from Abcam
Biology Products: